Cafepharma Today

September 19 2024 - Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
Havas Lynx explores pharma marketers’ role in addressing climate health crisis
Roche reports positive data from Phase III influenza treatment trial
ICER mulls GSK COPD drugs ahead of next Medicare negotiation
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

BioMarin Pharmaceutical shares rise on long-term outlook for genetic disorder treatment
Yahoo/AP
Friday, August 22, 2008 - 7:22pm
tags:
FDA rule on drug labeling attracts praise from drugmakers, ire from lawyers
Yahoo/AP
Friday, August 22, 2008 - 7:21pm
tags:
Pharma Deals: Start Hostile. Get Friendly.
WSJ Online
Friday, August 22, 2008 - 7:20pm
tags:
King Pharma raises pressure on rival
Financial Times
Friday, August 22, 2008 - 7:19pm
tags:
Abbott Tries a Crash Diet
Motley Fool
Friday, August 22, 2008 - 4:27pm
tags:
Amgen's Nplate Approved by U.S. for Bleeding Disorder
Bloomberg
Friday, August 22, 2008 - 3:18pm
tags:
Alpharma shares surge on King buyout offer
Forbes
Friday, August 22, 2008 - 3:17pm
tags:
Genentech Ditches Stock Options to Fund $371 Million Retention Plan
WSJ Online
Friday, August 22, 2008 - 10:02am
tags:
Merger Watch: APP Pharmaceuticals - Fresenius
Seeking Alpha
Friday, August 22, 2008 - 10:01am
tags:
Onyx and Bayer say patients are enrolling in trial of Nexavar for liver cancer
Yahoo/AP
Friday, August 22, 2008 - 9:39am
tags:
Eli Lilly's Cymbalta gets expanded European approval as anxiety disorder treatment
Yahoo/AP
Friday, August 22, 2008 - 9:36am
tags:
Fresenius Stays Strong in Tough Times
Businessweek
Friday, August 22, 2008 - 9:34am
tags:
FDA: Vytorin Not Linked to Cancer Risk
WSJ Online
Friday, August 22, 2008 - 9:33am
tags:
King Pharmaceuticals Bids $1.38 Billion for Alpharma
Bloomberg
Friday, August 22, 2008 - 9:30am
tags:
The Genentech Guessing Game - What Will Roche Offer Next?
Seeking Alpha
Thursday, August 21, 2008 - 9:02pm
tags:
DNA analysis heralds a health care revolution
Fortune
Thursday, August 21, 2008 - 9:01pm
tags:
PDL BioPharma's Partnership Makes Sense
Motley Fool
Thursday, August 21, 2008 - 5:54pm
tags:
Johnson & Johnson Gets Rejected
Motley Fool
Thursday, August 21, 2008 - 5:50pm
tags:
Congressmen demand Merck, Schering-Plough supply info on possible Vytorin cancer risk
Yahoo/AP
Thursday, August 21, 2008 - 5:34pm
tags:
A Gardasil Gotcha
Motley Fool
Thursday, August 21, 2008 - 5:22pm
tags:

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

FDA Approves Fasenra for Eosinophilic Granulomatosis with Polyangiitis
pharmexec
FDA Approves Keytruda Plus Pemetrexed, Platinum Chemotherapy for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
pharmexec
Keytruda Demonstrates Superior Overall Survival vs. Yervoy in Advanced Melanoma
pharmexec
CAR-T For Autoimmune Disorders
In the Pipeline
A Better Response to Inflammation: Q&A with Dr. Ira Spector
pharmexec
Braftovi Plus Mektovi Demonstrates Sustained Efficiency in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
pharmexec
GSK Launches Brooke Shields’ Led Campaign Promoting Shingles Vaccine
pharmexec
Pharma Pulse: 9/18/24: How Drug Shortages Affect Pharmacovigilance, Long Strange Trip Continues for Psychedelics & more
pharmexec
Pharmaceutical Executive: September 2024 Issue (PDF)
pharmexec

Latest Jobs

Account Manager-Los Angeles-Ophthalmics
Los Angeles, California, 90079
Sun Pharmaceutical Industries, Inc.
Regional Sales Manager - Eyecare - East Region
Miami, Florida, 33222
PV8 US Innovex Inc.
Business Development Manager- Tampa, Florida
Tampa, Florida, 33646
Hanger Clinic
Neuroscience Account Manager (Psychiatry) - Burbank, CA
Burbank, California, 91520
Vanda Pharmaceuticals
Territory Account Associate- Grand Rapids, MI
Grand Rapids, Michigan, 49528
Amplity Health
Surgical Solutions Field Sales Associate - Remote
Milwaukee, Wisconsin, 53244
W.L. Gore & Associates
Manager, Business Development - Physician Relations - Days - Full-Time
Baton Rouge, Louisiana, 70873
Woman's Hospital
Area Business Manager - Pulmonology - Greenville, SC
Asheville, North Carolina, 28814
Sanofi
Area Manager, Specialty Atlantic Region
Fields, Oregon, 97710
CSL Behring
Territory Manager (PCP) (Madison, AL)
Huntsville, Alabama, 35824
Bausch Health
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information